Volume 3 Supplement 2
21st European Workshop for Rheumatology Research
A single nucleotide polymorphism on the IL-10 locus defines an expression polymorphism and a possible risk factor to develop RA
© BioMed Central Ltd 2001
Received: 15 January 2001
Published: 26 January 2001
IL-10 production differs between individuals. We have evaluated the IL-10 production in whole blood cultures with/without LPS. The comparison of monozygotic twins, sibs and unrelated individuals yielded an estimate of heritability of 70% (Lancet 98). Moreover the ex-vivo IL-10 production was associated with haplotypes defined by alleles of CA-repeats (PNAS 98). In line with these results we have demonstrated that the interindividual differences in production of mRNA encoding IL-10 are similar than the interindividual differences in IL-10 protein production (Rheumatology 2000).
to define SNPs associated with common haplotypes. B) to study the association of IL-10 production with haplotypes/SNPs. C) to measure the distribution of IL-10 SNPs in RA versus controls. Methods: DNA of high and low IL10 producers were sequenced. Subsequently, the association between LPS-induced IL-10 production and previously described (Lancet 98) panel was analyzed.
The following SNPs were identified: -3575 A to G, -2849 A to G, -2763 A to C and -1330 A to G. Previously (Genes and Immunity 99) we have identified 4 ancestral IL-10 haplotypes. The current SNP's on: IL10.1 R3-AAAA-(IL10G)-GCC, IL10.2 R2-TGCG-(IL10G)-ACC, IL10.3 R2-AGAA-(IL10G)-GCC, and IL10.4 R2-TGCC-(IL10G)-ATA. To investigate whether these SNP's were functional we analyzed the LPS-induced IL-10 production of 161 healthy donors with a specific genotype: -3575: AA (n = 38) 1896 ng/ml, AT (n = 76) 3232 ng/ml, TT (n = 47) 3195 ng/ml. -2849: AA (n = 21) 2115 ng/ml, AG (n = 75) 2950 ng/ml, GG (n = 65) 3111 ng/ml (Mann-Whitney test both P < 0.05). Next, the analysis was repeated in a different group of donors: 135 partners of patients with SLE/MS: -3575: AA (n = 29) 4190 ng/ml, AT (n = 71) 4521 ng/ml, TT (n = 35) 4401 ng/ml (MW-test P = 0.6).
2849: AA (n = 26) 3845 ng/ml, AG (n = 41) 4577 ng/ml, GG (n = 68) 4543 ng/ml (MW-test P = 0.04, for G carrier versus non G: P = 0.02). Next, the distribution of -2849 SNP was compared in RA patients compared to controls. Control-Panels were 1) partners of MS-SLE patients (n = 135) and 2) organ donors (n = 168). RA-patients were: 1) incident RA cases, 2) outpatient consecutive RA and 3) RA patients from our early arthritis cohort.